Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer’s disease drug treatment: Dutch population-based inception cohort study
Ali Alghamdi, Spyros Balafas, Jens H J Bos, Barbara C van Munster, Karim Rafie, Amalia M Dolga, Eelko Hak · 2026
Read Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer’s disease drug treatment: Dutch population-based inception cohort study by Ali Alghamdi, Spyros Balafas, Jens H J Bos, Barbara C van Munster, Karim Rafie, Amalia M Dolga, Eelko Hak (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13289104.txt.
Description
Ali Alghamdi and colleagues study herpes drugs and later Alzheimer's care in 2026. Their study uses Dutch pharmacy data. It spans 1994 to 2024. Adults aged 50 to 80 took part. None had past dementia or Alzheimer's drugs.
The set held 262,757 adults in all. Users of herpes drugs numbered 23,887. Each user was matched to ten non-users. In all, 2,495 people later started Alzheimer's drugs. Herpes drug use tied to far lower starts. The tie held in both time spans. All three herpes drugs showed the tie. The authors urge trials to test the link. Herpes flares may play a part in Alzheimer's.
Catalog record
| CREATOR | Ali Alghamdi, Spyros Balafas, Jens H J Bos, Barbara C van Munster, Karim Rafie, Amalia M Dolga, Eelko Hak |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39846 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |